SUNDAY, NOVEMBER 3 MAIN TRAINING COURSES - eurogin

Nov 4, 2013 - The main training courses are designed to provide summaries of the ... Speakers will present only accepted evidence-based scientific ...... OC 18-8 ♢ Six years experience in 180.000 cases with LBC and computer assistance.
1MB Sizes 0 Downloads 188 Views
S U N DAY, N O V E M B E R

3

MAIN TRAINING COURSES The main training courses are designed to provide summaries of the most relevant knowledge on HPV infection and associated diseases with the aim of assisting physicians and educators. The topics covered range from the basic science fundamentals to emerging issues and the clinical uses of screening technologies, prophylactic HPV vaccines and extending to HPV-related diseases in external genitalia and head & neck. Speakers will present only accepted evidence-based scientific information that has been published in the peer-reviewed medical literature.

MTC 1 Break HPV11:00 infection Coffee - 11:30and diseases: the global view

Auditorium

Chair: S. Franceschi MTC 1-1  The burden of HPV-associated diseases

8:30 - 10:00 S. Franceschi

MTC 1-2  Epidemiology of HPV infection and related cancers - cervix vs. head & neck L. Alemany

France Spain

MTC 1-3  Natural history: current knowledge and perspectives

N. Wentzensen USA

MTC 1-4  HPV life cycle – an overview

J.

Doorbar

UK

 Discussion

Coffee Break 10:00 - 10:30

MTC 2

Current standards for cervical cancer control: screening and vaccination, practices and challenges

Auditorium 10:30 - 12:15

Chair: X. Bosch MTC 2-1  HPV screening strategies: new evidence

J

MTC 2-2  HPV screening: current and future perspectives

P. Snijders

The Netherlands

MTC 2-3  HPV vaccines: update on efficacy, impact and safety profile

S. Garland

Australia

UK

MTC 2-4  HPV vaccines: implementation and experiences, strengths and weaknesses P. L. Lopalco

Sweden

MTC 2-5  WHO HPV vaccines recommendations

Switzerland

 Discussion

14

Cuzick

S. Wang

S U N DAY,

N OV E M B E R

3

O R A L C O M M U N I CAT I O N S OC 1

Molecular markers

Sala Verde

Chair: P. Snijders

8:30 – 10:00

OC 1-1  Methylation of the HPV16 upstream regulatory region in relation to

HPV physical status in tonsillar and anal cancer OC 1-2  Integration and methylation status of E2-binding sites in HPV 16

in vulvar and vaginal carcinoma.

E. Prigge

Germany

G. Lillsunde-Larsson Sweden

OC 1-3  Methylation of viral and host genes in HPV-16 associated cervical lesions K. Louvanto

Canada

OC 1-4  Discovery of new methylation markers to improve early detection

of high-grade cervical intraepithelial neoplasia (CIN2/3)

A. Boers

The Netherlands

OC 1-5  HPV manipulation of the SUMO pathway

S. Chiocca

Italy

OC 1-6  Clinical validation of P16INK4a/KI-67 for the use in rotinely stained smears

S. Tiews

Germany

OC 1-7  Detection and quantification of HPV E7 oncoproteins in cervical smears

P. Jansen-Dürr Austria

OC 1-8  Development of a robust immunofluorescence technique to detect

HPV E4 protein in liquid based cytology (LBC) samples

R. Devine

UK

A. King

The Netherlands

X. van Ostade

Belgium

J.

Portugal

OC 1-9  Genetic variability in the major capsid L1 protein of human

papillomavirus type 16 (HPV16) in the Netherlands OC 1-10  Proteomic analysis of the cervicovaginal fluid leads to identification

of biomarkers for cervix cancer OC 1-11  MIR-125B expression in HPV infection and cervical cancer development:

Ribeir